Viewing Study NCT03432533


Ignite Creation Date: 2025-12-25 @ 3:03 AM
Ignite Modification Date: 2026-01-01 @ 5:23 AM
Study NCT ID: NCT03432533
Status: COMPLETED
Last Update Posted: 2020-11-23
First Post: 2018-01-30
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis
Sponsor: Amgen
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Post-Menopausal Osteoporosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Post-Menopausal osteoporosis View